Black Rock Inc. Lixte Biotechnology Holdings, Inc. Transaction History

Black Rock Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$0.12 - $0.35 $1,575 - $4,593	-13,125 Closed	0 $0
Q1 2022 May 12, 2022	SELL	$0.16 - $0.35 $108 - $236	-675 Reduced 4.89%	13,125 $16,000
Q4 2021 Feb 10, 2022	BUY	$0.21 - $0.57 $78 - $213	375 Added 2.79%	13,800 $16,000
Q3 2021 Nov 09, 2021	BUY	$0.52 - $0.85 $4,589 - $7,502	8,826 Added 191.91%	13,425 $28,000
Q2 2021 Aug 11, 2021	BUY	$0.46 - $0.89 $2,115 - $4,093	4,599 New	4,599 $14,000

Ticker LIXT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,646,600
Market Cap $33M
Description
Lixte Biotechnology Holdings, Inc. operates as a drug discovery company that uses biomarker technology to identify enzyme targets related with serious common diseases and designs novel compounds to attack those targets. The company primarily focuses on inhibitors of protein phosphatases that are used alone and in combination with cytotoxic agent...

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

Stay updated on Black Rock Inc. with notifications on news.